EP4143196A4
(en )
2024-04-17
PI3K-a INHIBITORS AND METHODS OF USE THEREOF
EP3969439A4
(en )
2023-01-11
Acss2 inhibitors and methods of use thereof
EP3986894A4
(en )
2023-08-09
Ectonucleotidase inhibitors and methods of use thereof
EP4146236A4
(en )
2024-11-27
Copper-containing theragnostic compounds and methods of use
CA3262145A1
(en )
2024-01-25
Aza-quinazoline compounds and methods of use
EP4153586A4
(en )
2024-07-10
Substituted pyrazolyl compounds and methods of use thereof
EP3959197A4
(en )
2022-10-12
Papd5 inhibitors and methods of use thereof
EP4175943A4
(en )
2023-11-15
Dual-functional compounds and methods of use
CA3248844A1
(en )
2023-07-27
Anti-b7-h3 compounds and methods of use
EP4329735A4
(en )
2025-03-05
Kcnt1 inhibitors and methods of use
EP3976039A4
(en )
2023-06-07
Bisaminoquinolines and bisaminoacridines compounds and methods of their use
HK40086352A
(en )
2023-08-18
Compounds and methods of use
HK40113303A
(en )
2025-02-14
Positive nmda-modulating compounds and methods of use thereof
HK40120643A
(en )
2025-08-22
Aza-quinazoline compounds and methods of use
HK40120392A
(en )
2025-08-15
Compounds and methods of use
CA3248829A1
(en )
2023-07-27
Anti-b7-h3 compounds and methods of use
HK40124187A
(en )
2025-11-07
Pyrimidopyrimidone compounds and methods of use thereof
HK40092054A
(en )
2023-12-15
Tetrahydropyrazolo-pyrazinyl-dihydroimidazolone or tetrahydropyrazolo-pyridinyl-dihydroimidazolone compounds and methods of using same
HK40053173B
(en )
2023-09-01
Compounds and methods of use
HK40072716A
(en )
2022-12-02
Compounds and methods of use
HK40105288A
(en )
2024-08-09
Pyridone compounds and methods of use
HK40103407A
(en )
2024-06-28
Urolithin derivatives and methods of use thereof
EP4214196A4
(en )
2025-02-19
Glycerol compounds and methods of use
HK40087353A
(en )
2023-09-08
Tie2-binding agents and methods of use
HK40093465A
(en )
2024-01-05
Lair-1-binding agents and methods of use thereof